# Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy

> **NCT03547375** · PHASE2 · UNKNOWN · sponsor: **Anhui Provincial Hospital** · enrollment: 69 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Apatinib

## Key facts

- **NCT ID:** NCT03547375
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-01
- **Primary completion:** 2019-12-01
- **Final completion:** 2020-06-01
- **Target enrollment:** 69 (ESTIMATED)
- **Last updated:** 2018-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03547375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03547375, "Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03547375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*